Abeta42-IN-7 (Compound CT-01) is a brain-penetrant and selective amyloid-beta42 (Abeta42) inhibitor. Abeta42-IN-7 inhibits Abeta42s assembly into neurotoxic soluble oligomers and extracellular fibrillary aggregates. Abeta42-IN-7 exerts neuroprotective effects by reducing amyloid-mediated neuronal toxicity. Abeta42-IN-7 can be used in research on Alzheimers disease (AD)[1].
Molekulargewicht:
545.23
Formel:
C22H19Br2N5O2
Target-Kategorie:
Amyloid-beta
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten